IF a dual senomorphic cocktail of metformin (0.1% w/w in chow, ≈150 mg/kg/day, oral, continuous) and recombinant IL-1 receptor antagonist (rIL-1ra / anakinra, 50 mg/kg/day subcutaneous injection, 5 days/week) is co-administered for 12 weeks to naturally aged, frail C57BL/6J mice (22–24 months, both sexes, confirmed frail by frailty index ≥ 0.25 prior to enrollment),

THEN the following measurable outcomes will be observed compared to vehicle-treated age-matched controls:

• ≥ 40% reduction in circulating IL-6 and CXCL8/KC (plasma ELISA)
• ≥ 35% reduction in tissue-level nuclear GATA4 and NF-κB p65 immunofluorescence signal in liver and skeletal muscle
• Significant restoration (≥ 25% increase) of skeletal stem/progenitor cell (SSPC) colony-forming unit (CFU-F) capacity from femoral bone marrow
• ≥ 20% improvement in composite frailty index score
• Reduction in CD36+ senescent cell frequency in liver (flow cytometry), serving as a pharmacodynamic biomarker of SASP circuit disengagement
• With NO increase in tissue apoptosis (TUNEL) or wound-healing impairment (tail-clip assay), distinguishing this from senolytic mechanisms

BECAUSE the following causal chain is operative:

1. In aged organisms, persistent DNA damage response (DDR) signaling suppresses p62/SQSTM1-mediated selective autophagy, causing pathological stabilization and nuclear accumulation of GATA4 in senescent cells; this GATA4 accumulation directly activates NF-κB-dependent transcription of primary SASP cytokines, including IL-1α, IL-6, and CXCL8 — establishing a self-reinforcing inflammatory secretome (Senescent microglia limit remyelination through p16INK4a-expressing SASP circuits)[https://doi.org/10.1101/2024.05.23.595605].

2. Metformin activates AMPK, which restores autophagic flux and promotes p62-mediated GATA4 degradation, thereby cutting the SASP off at its intracellular transcriptional origin, reducing NF-κB-dependent pro-inflammatory gene expression; in vivo, metformin at this dose reduced hepatocyte HMGB1 nuclear exclusion, telomere-associated foci (TAF), and nuclear karyomegaly in radiation-frail mice, demonstrating direct senostatic activity in tissues (Metformin reduced late-life hepatocyte senescence markers and hippocampal senescence)[https://doi.org/10.7554/elife.75492].

3. Despite intracellular GATA4 suppression, already-secreted extracellular IL-1α and IL-1β from the accumulated senescent cell burden continue to drive autocrine and paracrine amplification of the SASP through IL-1R1 → MyD88 → NF-κB and IL-1R1 → C/EBPβ signaling; rIL-1ra competitively occupies IL-1R1 without agonist activity, severing this extracellular amplification loop and suppressing the downstream cytokine cascade including IL-6 and IL-8 — the two most proximal drivers of "inflammaging" paracrine spread (IL-6/JAK/STAT3 and TNFα/NF-κB hallmark pathways are central to SASP-driven tissue dysfunction)[https://doi.org/10.1038/s41422-020-0314-9].

4. Critically, IL-1α surface-bound signaling on senes...

SENS category: RepleniSENS

Key references: • doi.org/10.1101/2024.05.23.595605]. • doi.org/10.7554/elife.75492]. • doi.org/10.1038/s41422-020-0314-9]. • doi.org/10.1073/pnas.1810692116]. • doi.org/10.1101/2025.05.07.648438].